Results 51 to 60 of about 481,852 (106)

Effects of Initiating Raltegravir-Based Versus Efavirenz-Based Antiretroviral Regimens During Pregnancy on Weight Changes and Perinatal Outcomes: NICHD P1081. [PDF]

J Acquir Immune Defic Syndr, 2022
Coutinho CM, Warshaw MG, Duarte G, Stek A, Violari A, Hofer CB, Deville JG, Ngocho JS, Pilotto JH, Correa MD, Shapiro DE, Fuller TL, Chakhtoura N, Mirochnick M, João EC.   +14 more
europepmc   +1 more source

Influence of UGT1A1 and SLC22A6 polymorphisms on the population pharmacokinetics and pharmacodynamics of raltegravir in HIV-infected adults: a NEAT001/ANRS143 sub-study. [PDF]

Pharmacogenomics J, 2023
Gurjar R, Dickinson L, Carr D, Stöhr W, Bonora S, Owen A, D'Avolio A, Cursley A, De Castro N, Fätkenheuer G, Vandekerckhove L, Di Perri G, Pozniak A, Schwimmer C, Raffi F, Boffito M, NEAT001/ANRS143 Study Group.   +16 more
europepmc   +1 more source

Influence of concurrent oral calcium carbonate supplementation on steady-state pharmacokinetics of once daily oral raltegravir in persons with HIV: a protocol for a prospective open-label non-randomised study in Canada. [PDF]

BMJ Open
Teixeira Nunes Porto LL, Doyle MA, Zhang G, Tremblay N, Yazji B, Kanji S, Cameron DW.   +6 more
europepmc   +1 more source

Mapping the Gut Microbiota Composition in the Context of Raltegravir, Dolutegravir, and Bictegravir-A Scoping Review. [PDF]

Int J Mol Sci
Gáspár Z, Lakatos B.
europepmc   +1 more source

Monitoring SARS-CoV-2 Viral Load and CD4+ T-cell Count After ART in a Patient Diagnosed With AIDS Following SARS-CoV-2 Infection: A Case Report. [PDF]

Cureus, 2023
Umekage Y, Hatayama M, Yagita A, Nitanai K, Yanada H, Shigaki R, Minami Y, Sasaki T.   +7 more
europepmc   +1 more source

Analysis of raltegravir analogs to enhance inhibitory efficiency against HIV integrase. [PDF]

Sci Rep
Sabaghian H, Yoosefian M.
europepmc   +1 more source

Transfer of antiretroviral drugs into breastmilk: a prospective study from the Swiss Mother and Child HIV Cohort Study. [PDF]

J Antimicrob Chemother, 2022
Aebi-Popp K, Kahlert CR, Crisinel PA, Decosterd L, Saldanha SA, Hoesli I, Martinez De Tejada B, Duppenthaler A, Rauch A, Marzolini C, Swiss Mother and Child HIV Cohort Study (SHCS).   +10 more
europepmc   +1 more source

Antiretroviral medications for pediatric use in the context of the Unified Health System: are there therapeutic gaps in Brazil? [PDF]

Rev Paul Pediatr
Costa SMD, Aguiar PM.
europepmc   +1 more source

In silico prediction of potential inhibitors for SARS-CoV-2 Omicron variant using molecular docking and dynamics simulation-based drug repurposing. [PDF]

J Mol Model, 2023
Mohamed EAR, Abdel-Rahman IM, Zaki MEA, Al-Khdhairawi A, Abdelhamid MM, Alqaisi AM, Rahim LBA, Abu-Hussein B, El-Sheikh AAK, Abdelwahab SF, Hassan HA.   +10 more
europepmc   +1 more source

Repurposing raltegravir for reducing inflammation and treating cancer: a bioinformatics analysis. [PDF]

Sci Rep
Nikfarjam Z, Rakhshi R, Zargari F, Aalikhani M, Hasan-Abad AM, Bazi Z.   +5 more
europepmc   +1 more source